Considering the difficulty of characterizing CF patient groups with class IV, V, or VI mutations, taking into account the possibility of normal TNM values and sweat test, in association with the residual expression of the CFTR protein, new diagnostic tools should be provided, and a potential tool is NPD [28]. This evidence concerns the gene CFTR and cystic fibrosis.